Knoll Capital Management, LLC Galmed Pharmaceuticals Ltd. Transaction History

Knoll Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.61 - $6.75 $525,955 - $983,434	-145,694 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.62 - $7.11 $279,071 - $429,479	-60,405 Reduced 29.31%	145,694 $696,000
Q1 2019 May 15, 2019	SELL	$7.27 - $9.07 $28,360 - $35,382	-3,901 Reduced 1.86%	206,099 $1.68 Million
Q2 2018 Aug 14, 2018	BUY	$5.04 - $17.96 $1.06 Million - $3.77 Million	210,000 New	210,000 $2.5 Million

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $122M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.